220 related articles for article (PubMed ID: 193662)
1. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies (cold lymphocytotoxins, antiactin antibodies and antinuclear factors) in nasopharyngeal carcinoma patients.
Lamelin JP; de-The G; Revillard JP; Gabbiani G
IARC Sci Publ (1971); 1978; (20):523-36. PubMed ID: 215532
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
Henle W; Henle G
Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
[No Abstract] [Full Text] [Related]
4. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
Joncas JH; Rioux E; Wastiaux JP; Leyritz M; Robillard L; Menezes J
Can Med Assoc J; 1976 Nov; 115(9):858-60. PubMed ID: 186168
[TBL] [Abstract][Full Text] [Related]
5. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
Gunven P
G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
[No Abstract] [Full Text] [Related]
6. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in three populations of Burkitt's lymphoma patients.
Vainio E; Lenoir GM; Franklin RM
Clin Exp Immunol; 1983 Nov; 54(2):387-96. PubMed ID: 6317239
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus.
Rowe M; Finke J; Szigeti R; Klein G
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1217-28. PubMed ID: 2838572
[TBL] [Abstract][Full Text] [Related]
9. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
[TBL] [Abstract][Full Text] [Related]
10. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.
Jondal M; Gunven P
Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292
[TBL] [Abstract][Full Text] [Related]
11. Immunologic markers for Epstein-Barr virus in the control of nasopharyngeal carcinoma and Burkitt lymphoma.
Levine PH
Cancer Detect Prev Suppl; 1987; 1():217-23. PubMed ID: 2826001
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
Gunvén P; Klein G; Henle G; Henle W; Clifford P
Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
[No Abstract] [Full Text] [Related]
13. Evidence for an etiologic relation of the Epstein-Barr virus to human malignancies.
Henle W; Henle G
Laryngoscope; 1977 Apr; 87(4 Pt 1):467-73. PubMed ID: 190497
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiology and nature of the association between herpesviruses (EBV and herpes simplex) and several human tumors. Recent results].
de-Thé G
Bull Cancer; 1976; 63(3):417-26. PubMed ID: 187271
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
Liu MT; Yeh CY
Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma.
Inoue M; Klein G
Clin Exp Immunol; 1970 Jul; 7(1):39-50. PubMed ID: 4320551
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma.
Klein G
Isr J Med Sci; 1977 Jul; 13(7):716-24. PubMed ID: 200586
[No Abstract] [Full Text] [Related]
18. The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa.
Geser A; Brubaker G; Olwit GW
Rev Epidemiol Sante Publique; 1980 Oct; 28(3):307-21. PubMed ID: 6258200
[TBL] [Abstract][Full Text] [Related]
19. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
Morrow RH; Sever JL; Henderson BE
Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
[No Abstract] [Full Text] [Related]
20. Malaria antibody levels in patients with nasopharyngeal carcinoma.
Yadav M; Prasad U
Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):234-7. PubMed ID: 6095462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
